Mechanosensitive and profibrotic signaling pathways, such as YAP/TGFβ, are also implicated in multiple aspects of valvular heart disease and therefore considered potential targets for therapeutic interventions and prognostic biomarkers with the implications to improve the management of valvular heart disease [44]. Here, TGFB1 is linked to heart valve disorder.